To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

About eight in 10 men will be diagnosed with prostate cancer in their lifetime. It’s the second leading cause of cancer death in men, behind only heart disease. About 1 in 8 men will be diagnosed with ...

There is a 'large variation' between GP surgeries when it comes to the use of a prostate cancer test for men who have no ...

The Decipher Prostate Metastatic test is now available for metastatic prostate cancer, covered by Medicare for all risk levels. It helps clinicians determine which patients may benefit from treatment, ...

WASHINGTON D.C. (WPVI) -- The Preventive Services Task Force is changing recommendations that can affect millions of middle-aged men. Five years ago, it opposed routine screening for prostate cancer, ...

Former President Joe Biden announced this weekend that he has been diagnosed with an aggressive form of prostate cancer, the second leading cause of cancer death for men in the United States. About 1 ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

The test can differentiate between various grades of cancer, helping men avoid unnecessary biopsies. Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However ...

A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine. Led by a team from ...